Top Suppliers:I want be here

4097-22-7

4097-22-7 structure
4097-22-7 structure

Name 2',3'-Dideoxyadenosine
Synonyms 9-(2,3-dideoxy-β-D-glycero-pentofuranosyl)-9H-purin-6-amine (2′,3′-dideoxyadenosine)
DDA
((2S,5R)-5-(6-Amino-9H-purin-9-yl)tetrahydrofuran-2-yl)methanol
Dideoxyadenosine, 10 mM in DMSO
DIDEOXYADENOSINE ,DDA
[(2S,5R)-5-(6-aminopurin-9-yl)oxolan-2-yl]methanol
[(2S,5R)-5-(6-Aminopurin-9-yl)oxolan-2-yl]methanol
2,3-Dideoxyadenosine (ddA) extrapure
ddA 9-(2,3-Dideoxy-beta-D-ribofuranosyl)adenine
EINECS 223-853-2
Didanosine Impurity 7(Didanosine Impurity G)
Didanosine Related Compound B (25 mg) (2',3'-dideoxyadenosine)
Didanosine impurity G CRS
9-(2,3-Dideoxy-beta-D-glycero-pentofuranosyl)-9H-purin-6-amine (2',3'-Dideoxyadenosine)
9-(2,3-Dideoxy-β-D-ribofuranosyl)adenine
MFCD00010534
Didanosine Related Compound B (2'',3''-dideoxyadenosine)
Didanosine Related CoMpound B
Dideoxyadenosine //BP
DIDEOXYADENOSINE
2',3'-dideoxy adenosine DDA, antiviral drug, related substance B of ddI GL101975
9-(2,3,5-trideoxy-β-D-glycero-pentofuranosyl)-9H-purin-6-amine (2′,3′,5′-trideoxyadenosine)
2',3'-ddA
9-(2,3-Dideoxy-beta-D-glycero-pento
2',3'-DIDEOXYADENOSINE extapure
Dideoxyadenosine
Didanosine impurity G
Adenosine, 2',3'-dideoxy
2', 3'-Dideoxyadenosine
6-Amino-9-(2',3'-dideoxy-b-D-glycero-pentofuranosyl)purine
[(2S,5R)-5-(6-Amino-9H-purin-9-yl)tetrahydrofuran-2-yl]methanol
Didanosine Related Compound B (2',3'-dideoxyadenosine)
Didanosine Impurity G
2’,3’-dideoxy-adenosin
9-(2,3-Dideoxy-beta-D-ribofuranosyl)adenine
BETA-D-2',3'-DIDEOXYADENOSINE
Didanosin Imp G
2',3'-Dideoxy-D-adenosine
2',3'-Dideoxyadenosine>
((2S,5R)-5-(6-Amino-9H-purin-9-yl)tetrahydrofuran-2-yl)Methanol
[(2S,5R)-5-(6-Amino-9H-purin-9-yl)tetrahydro-2-furanyl]methanol
Description 2',3'-Dideoxyadenosine is an inhibitor of HIV replication[1]. Antiretroviral activity[1]. Antiviral efficacy[1].
Related Catalog
Target

HIV[1]

In Vitro 2',3'-Dideoxyadenosine inhibits HIV-1 and simian immunodeficiency virus (SIV) in MT-4 cells with EC50s of 5.27 and 5.3 μM, respectively. 2',3'-Dideoxyadenosine inhibits HIV-1 and HIV-2 in human T-lymphocyte CEM cells with EC50s of 4 μM and 8 μM, respectively. 2',3'-Dideoxyadenosine inhibits HIV-1 and HIV-2 in Molt 4/C8 cells with EC50s of 4 μM and 5.5 μM, respectively. 2',3'-Dideoxyadenosine inhibits HIV-1 and HIV-2 in C8166 cells with EC50s of 17 μM and 22 μM, respectively. 2',3'-Dideoxyadenosine inhibits murine sarcoma virus (MSV) in C3H/3T3 cells with an EC50 of 24 μM[1].
References

[1]. Balzarini J, et al. Conversion of 2',3'-dideoxyadenosine (ddA) and 2',3'-didehydro-2',3'-dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus. FEBS Lett. 1997 Jun 30;410(2-3):324-8.

Density 1.8±0.1 g/cm3
Boiling Point 539.1±60.0 °C at 760 mmHg
Melting Point 181-184 °C(lit.)
Molecular Formula C10H13N5O2
Molecular Weight 235.242
Flash Point 279.9±32.9 °C
Exact Mass 235.106918
PSA 99.08000
LogP -0.43
Vapour Pressure 0.0±1.5 mmHg at 25°C
Index of Refraction 1.822
Storage condition 2-8°C

CHEMICAL IDENTIFICATION

RTECS NUMBER :
AU7358900
CHEMICAL NAME :
Adenosine, 2',3'-dideoxy-
CAS REGISTRY NUMBER :
4097-22-7
BEILSTEIN REFERENCE NO. :
0619924
LAST UPDATED :
199612
DATA ITEMS CITED :
11
MOLECULAR FORMULA :
C10-H13-N5-O2
MOLECULAR WEIGHT :
235.28

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
5 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1320 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
19600 mg/kg/28D-I
TOXIC EFFECTS :
Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol) Blood - changes in erythrocyte (RBC) count Nutritional and Gross Metabolic - weight loss or decreased weight gain

MUTATION DATA

TEST SYSTEM :
Rodent - mouse
DOSE/DURATION :
9 gm/kg/3D (Continuous)
REFERENCE :
EMMUEG Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- Volume(issue)/page/year: 18,168,1991
Personal Protective Equipment Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
Hazard Codes C
Risk Phrases R34
Safety Phrases 26-27-36/37/39-45
RIDADR NONH for all modes of transport
WGK Germany 2
RTECS AU7358900
HS Code 2934999090
HS Code 2934999090
Summary 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.